Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVIX
2401
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
| $1.69M | ﹤0.01% |
+32,900
| New | +$2.82M |
|
|
NIU
2402
Niu Technologies
NIU
$163M
| $1.69M | ﹤0.01% |
197,717
+118,367
| +149% | +$1.06M |
|
2403
Quad
QUAD
$513M
| $1.69M | ﹤0.01% |
361,000
+101,000
| +39% | +$631K |
|
2404
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $1.69M | ﹤0.01% |
+10,300
| New | +$1.61M |
|
2405
Oil States International
OIS
$539M
| $1.68M | ﹤0.01% |
103,000
-38,900
| -27% | -$591K |
|
2406
Fastenal
FAST
$58.5B
| $1.68M | ﹤0.01% |
90,776
-233,600
| -72% | -$4.18M |
|
|
GPL
2407
DELISTED
Great Panther Mining Limited
GPL
| $1.67M | ﹤0.01% |
327,697
+44,871
| +16% | +$237K |
|
2408
Colony Bankcorp
CBAN
$473M
| $1.67M | ﹤0.01% |
101,119
-2,692
| -3% | -$42.5K |
|
2409
Werner Enterprises
WERN
$2.33B
| $1.66M | ﹤0.01% |
45,663
-13,500
| -23% | -$494K |
|
|
HARP
2410
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.66M | ﹤0.01% |
11,190
+8,450
| +308% | +$1.28M |
|
2411
Princeton Bancorp
BPRN
$296M
| $1.65M | ﹤0.01% |
52,523
+3,700
| +8% | +$109K |
|
2412
Digital Turbine
APPS
$1.51B
| $1.65M | ﹤0.01% |
230,964
+70,064
| +44% | +$521K |
|
|
SIOX
2413
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.64M | ﹤0.01% |
320,423
+42,400
| +15% | +$235K |
|
2414
Tetra Tech
TTEK
$9.35B
| $1.64M | ﹤0.01% |
+95,100
| New | +$1.65M |
|
2415
Harvard Bioscience
HBIO
$30.3M
| $1.64M | ﹤0.01% |
53,600
+2,079
| +4% | +$59.8K |
|
2416
Cytokinetics
CYTK
$10.3B
| $1.63M | ﹤0.01% |
153,767
+83,467
| +119% | +$857K |
|
2417
abrdn Physical Palladium Shares ETF
PALL
$651M
| $1.63M | ﹤0.01% |
44,500
+20,500
| +85% | +$695K |
|
2418
Vanguard S&P 500 ETF
VOO
$1.04T
| $1.63M | ﹤0.01% |
+5,500
| New | +$1.56M |
|
2419
Purple Innovation
PRPL
$29.7M
| $1.63M | ﹤0.01% |
7,468
+4,556
| +156% | +$878K |
|
2420
SIGA Technologies
SIGA
$216M
| $1.62M | ﹤0.01% |
338,818
+127,218
| +60% | +$648K |
|
2421
Matsons
MATX
$6.5B
| $1.61M | ﹤0.01% |
39,500
+33,200
| +527% | +$1.27M |
|
|
MFGP
2422
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.61M | ﹤0.01% |
+114,790
| New | +$1.59M |
|
2423
Chicago Rivet & Machine Co
CVR
$9.98M
| $1.61M | ﹤0.01% |
62,410
-1,400
| -2% | -$36.8K |
|
|
AAWW
2424
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.61M | ﹤0.01% |
58,400
+24,100
| +70% | +$602K |
|
2425
ProShares UltraPro Dow 30
UDOW
$924M
| $1.6M | ﹤0.01% |
+51,600
| New | +$1.45M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.